Granulocyte colony-stimulating factor-associated complications and increase in leukocyte number.
Ferretti
G
G
Papaldo
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D009367:Neoplasm Staging; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D011994:Recombinant Proteins; D015251:Epirubicin; D003520:Cyclophosphamide